These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6787131)

  • 1. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells.
    Balk SP; Mescher MF
    J Immunol; 1981 Jul; 127(1):51-7. PubMed ID: 6787131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific reversal of cytolytic T lymphocyte--target cell interaction.
    Balk SP; Mescher MF
    J Supramol Struct Cell Biochem; 1981; 16(1):43-52. PubMed ID: 6795359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of cytolytic T lymphocyte binding to target cells in suspension.
    Balk SP; Walker J; Mescher MF
    J Immunol; 1981 Jun; 126(6):2177-83. PubMed ID: 6971889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of specificity in cytolytic T lymphocyte clones. The separate YAC-1-type (NK-like) and P815-type broad specificity killing patterns are both restricted to the larger cells within a clone but may be expressed independently in clones from different mouse strains.
    Shortman K; Wilson A
    J Immunol; 1986 Aug; 137(3):798-804. PubMed ID: 2424983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive inhibition of cytotoxic T lymphocyte-target cell conjugation. A direct evaluation of membrane antigens involved in cell-mediated immunity.
    Schick B; Berke G
    Transplantation; 1979 Jun; 27(6):365-8. PubMed ID: 111379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
    Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
    Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte-mediated cytolysis: dissociation of the binding and lytic mechanisms of the effector cell.
    Fishelson Z; Berke G
    J Immunol; 1978 Apr; 120(4):1121-6. PubMed ID: 305932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells.
    Gromkowski SH; Heagy W; Sanchez-Madrid F; Springer TA; Martz E
    J Immunol; 1983 Jun; 130(6):2546-51. PubMed ID: 6406593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessory cell requirements for the generation of cytolytic T lymphocytes.
    Lutz CT; Fitch FW
    J Immunol; 1979 Jun; 122(6):2598-604. PubMed ID: 109533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell destruction by cytotoxic T lymphocytes: the basis of reduced antitumor cell activity in syngeneic hosts.
    Fishelson Z; Berke G
    J Immunol; 1981 May; 126(5):2048-52. PubMed ID: 6783702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes.
    Sherman L; Mescher MF; Burakoff SJ
    J Immunol; 1979 Jul; 123(1):501-2. PubMed ID: 312884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of cytolytic T lymphocytes in vitro. X. Induction of primary and secondary CTL responses by the mitogen sodium periodate.
    Maryanski JL; Cerottini JC; Brunner KT
    J Immunol; 1979 Jan; 122(1):342-9. PubMed ID: 84021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.